Clinical trial
Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America
NCT00969319 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2009
- Completion date
- February 28, 2014
- Enrollment
- 105 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.